Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-02-11
1994-03-15
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514287, 546 65, 546101, C07D21704, A61K 3147
Patent
active
052946185
ABSTRACT:
A class of 1,2,3,4,4a,5,6,10b-octahydrobenz[f]isoquinoline compounds and pharmaceutically acceptable salts of formula I: ##STR1## wherein, R.sup.1 represents hydrocarbon;
REFERENCES:
patent: 4740602 (1988-04-01), Bottcher et al.
patent: 5049564 (1991-09-01), De Bernardis
Cannon et al, J. Med. Chem., vol. 19, No. 8, (1976), pp. 987-993.
Cannon et al, J. Med. Chem., vol. 22, No. 4 (1979), pp. 341-347.
Cannon et al, J. Med. Chem., vol. 23, No. 1 (1980) pp. 1-5.
Hahne et al., Arch. Pharm. (Weinheim) (1979), 312, 472-477.
Kumar et al, Indian J. Chem., Sec. B (1979), 17, 239-243.
Menard et al, Canadian Journal of Chemistry 52, No. 12 (1974), pp. 2316-2326.
Billington David C.
Russell Michael G. N.
Datlow Philip I.
DiPrima Joseph F.
Merck Sharp & Dohme Limited
North Robert J.
Shah Mukund J.
LandOfFree
Octahydrobenzisoquinoline derivatives as antipsychotic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydrobenzisoquinoline derivatives as antipsychotic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydrobenzisoquinoline derivatives as antipsychotic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536229